NICE Ltd vs UnitedHealth Group Inc — how do they compare? NICE Ltd trades at $94.34 (market cap $5.91B), while UnitedHealth Group Inc trades at $436.33 (market cap $382.83B). The key difference: UnitedHealth Group Inc is far larger — about 64.8× NICE Ltd's market cap, and UnitedHealth Group Inc pays a 2.2% dividend while NICE Ltd pays none. Which is the better fit depends on your goals.
| NICE | UNH | |
|---|---|---|
Market Cap | $5.91B | $382.83B |
Sector | Technology | Health |
52-Week High | $170.37 | $431.68 |
52-Week Low | $83.15 | $237.77 |
Enterprise Value | $5.69B | $429.52B |
Dividend Yield | — | 2.2% |
Signals from Pluang's Aura AI — not financial advice
NICE trades at $101.34, up 1.19% today, with a bullish technical signal and strong support near $99. The stock shows solid fundamentals with a P/E of 12.02, net income margin of 17.57%, and consistent earnings beats in recent quarters. Recent news highlights enterprise AI deployments with Banco do Brasil and Sopra Steria, reinforcing growth in customer engagement solutions.
The outlook remains positive with a consensus price target of $123.33, representing 22% upside potential. Risks include competitive pressures in AI software and potential margin compression, but analyst sentiment is strongly bullish with no sell ratings. Institutional interest is supported by robust cash flow generation and strategic AI expansions.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations of $4.94. Revenue growth remains robust, reaching $447.57 billion in 2025, though net margins have compressed to 2.68%. Recent corporate actions include a $2.32 dividend and ongoing share repurchases, while news highlights operational streamlining like reduced pediatric prior authorizations.
UNH's outlook is positive, driven by aging demographics and tech innovation in healthcare, offering upside to the $467.12 consensus target. Risks include regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. Institutional sentiment is strongly bullish, with 82.69% of analysts rating it a buy, supporting long-term growth prospects amid sector tailwinds.
Trailing returns across standard periods
Latest headlines on both assets
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →